We are live on ! Find out more
CEROW

CERo Therapeutics Warrants
CEROW

Delisted

CEROW was delisted on the 30th of October, 2025.

Back to rankings

49 hedge funds and large institutions have $3.54M invested in CERo Therapeutics Warrants in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

75% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 8

14% more funds holding

Funds holding: 43 → 49 (+6)

5% less capital invested

Capital invested by funds: $3.72M → $3.54M (-$181K)

Holders
49
Holders Change
+6
Holders Change %
+13.95%
% of All Funds
0.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
4
Reduced
2
Closed
8
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
-$4K

Top Buyers

Rank Fund Capital Flow
1
SCM
Shaolin Capital Management
Florida
+$19.7K
2
CCA
Castle Creek Arbitrage
Colorado
+$10.5K
3
WCMNY
Westchester Capital Management (New York)
New York
+$3.94K
4
DCM
Difesa Capital Management
New York
+$3.29K
5
CAC
Cowen and Company
New York
+$3.1K

Top Sellers

Rank Fund Capital Flow
1
MF
Magnetar Financial
Illinois
-$17K
2
AGM
Alpine Global Management
New York
-$8K
3
KPF
K2 Principal Fund
Ontario, Canada
-$6K
4
HIM
HGC Investment Management
Ontario, Canada
-$4K
5
BCM
Basso Capital Management
Connecticut
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
MP
1
Mangrove Partners
Connecticut
$1.68M – – –
RCM
2
Radcliffe Capital Management
Pennsylvania
$1.54M – – –
SCM
3
Segantii Capital Management
Hong Kong
$51K – – –
PC
4
Periscope Capital
Ontario, Canada
$40.6K +$1.38K +26,300 +3%
HCM
5
Highbridge Capital Management
New York
$21K – – –
MI
6
MMCAP International
Cayman Islands
$16.2K – – –
CF
7
Cantor Fitzgerald
New York
$16K – – –
SCM
8
Shaolin Capital Management
Florida
$16K +$19.7K +374,998 New
CS
9
Clear Street
New York
$15K +$866 +16,467 +5%
PAMP
10
Polar Asset Management Partners
Ontario, Canada
$12.9K – – –
SCM
11
Saba Capital Management
New York
$12.8K – – –
LA
12
Linden Advisors
New York
$12.6K – – –
AA
13
AQR Arbitrage
Connecticut
$9.82K – – –
ACM
14
Atalaya Capital Management
New York
$9K – – –
CCM
15
Context Capital Management
California
$9K – – –
CCA
16
Castle Creek Arbitrage
Colorado
$8.62K +$10.5K +200,000 New
QGA
17
Q Global Advisors
Texas
$7K – – –
TI
18
Telemetry Investments
New York
$5K – – –
Parallax Volatility Advisers
19
Parallax Volatility Advisers
California
$4.95K – – –
NAM
20
Nexpoint Asset Management
Texas
$4.69K – – –
PMAM
21
Picton Mahoney Asset Management
Ontario, Canada
$4K – – –
SRCM
22
Sage Rock Capital Management
New York
$3.96K – – –
WAM
23
Wolverine Asset Management
Illinois
$3.79K +$379 +7,204 +9%
WCMNY
24
Westchester Capital Management (New York)
New York
$2.95K +$3.94K +74,998 New
CH
25
CVI Holdings
Delaware
$2.86K -$1.31K -24,975 -26%
1
2 3

CEROW Hedge Fund Activity: Q4 2022 in Review

49 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics Warrants (CEROW) for Q4 2022, worth a combined $3.54M — down 4.9% from $3.72M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new CEROW positions and 8 closed out — a net gain of 6 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Shaolin Capital Management, opening a new position worth an estimated $19.7K. The largest seller was Magnetar Financial, exiting entirely with an estimated $17K sold.

  • 49 institutional investors held CERo Therapeutics Warrants (CEROW) as of Q4 2022, up from 43 in Q3 2022.
  • Funds reported $3.54M of CERo Therapeutics Warrants stock for Q4 2022, down 4.9% quarter-over-quarter.
  • 14 funds opened new CERo Therapeutics Warrants positions in Q4 2022 and 8 closed out, a net change of +6 holders.
  • The largest CERo Therapeutics Warrants buyer in Q4 2022 was Shaolin Capital Management, an estimated $19.7K added.
  • The largest CERo Therapeutics Warrants seller in Q4 2022 was Magnetar Financial, an estimated $17K sold.

Based on aggregated 13F filings for Q4 2022.